Guo Xihan, Ni Juan, Xue Jinglun, Wang Xu
School of Life Sciences, The Engineering Research Center of Sustainable Development and Utilization of Biomass Energy, Yunnan Normal University, Kunming, Yunnan, China; School of Life Sciences, Yunnan University, Kunming, Yunnan, China.
School of Life Sciences, The Engineering Research Center of Sustainable Development and Utilization of Biomass Energy, Yunnan Normal University, Kunming, Yunnan, China.
Exp Toxicol Pathol. 2017 Mar 2;69(3):163-171. doi: 10.1016/j.etp.2016.12.009. Epub 2017 Jan 7.
Bulbus Fritillaria cirrhosa D. Don (BFC) has been used in China as a folk medicine for the treatment of cough and asthma for more than 2000 years. The antitussive and antiasthmatic effects of BFC have been reported before, nevertheless its toxicity and safety have not been documented. This study investigated the possible effects of BFC on spindle assembly checkpoint (SAC), mitotic fidelity and genomic stability in human NCM460 colon epithelial cells.
Cells were treated with BFC (0, 20, 40, 80 and 160μg/ml) for 24, 48 and 72h and harvested differently according to the biomarkers observed. Mitotic aberrations were assessed by the biomarkers of chromosome misalignment (CMA), chromosome lagging (CL) and chromatin bridge (CB). Frequencies of micronuclei (MN), nucleoplasmic bridge and nuclear bud (NB) in cytokinesis-block micronucleus assay were used as indicators of genomic instability (GIN). SAC activity was determined by anaphase to metaphase ratio (AMR) and the expression of several SAC genes, including CENP-E, Mps1, Bub1, Mad-1, BubR1 and Mad-2.
Compared with the control, cells in BFC treated groups (80 and 160μg/ml) showed: 1) increased AMR (p<0.05), up-regulated expression of Mps1, Bub1 and Mad-1 (p<0.05) and down-regulated expression of CENP-E, BubR1 and Mad-2 (p<0.05); 2) increased frequencies of CMA, CL and CB (p<0.01); 3) increased incidences of MN and NB (p<0.01).
This study revealed for the first time that BFC causes mitotic aberrations and GIN in human colon epithelial cells and these effects maybe the result of SAC dysfunction.
川贝母在中国作为一种民间药物用于治疗咳嗽和哮喘已有2000多年的历史。此前已有关于川贝母镇咳和平喘作用的报道,但其毒性和安全性尚未见文献记载。本研究调查了川贝母对人NCM460结肠上皮细胞纺锤体组装检查点(SAC)、有丝分裂保真度和基因组稳定性的可能影响。
用川贝母(0、20、40、80和160μg/ml)处理细胞24、48和72小时,并根据观察到的生物标志物进行不同的收获。通过染色体错配(CMA)、染色体滞后(CL)和染色质桥(CB)的生物标志物评估有丝分裂畸变。胞质分裂阻滞微核试验中微核(MN)、核质桥和核芽(NB)的频率用作基因组不稳定性(GIN)的指标。通过后期与中期比率(AMR)以及包括CENP-E、Mps1、Bub1、Mad-1、BubR1和Mad-2在内的几个SAC基因的表达来确定SAC活性。
与对照组相比,川贝母处理组(80和160μg/ml)的细胞显示:1)AMR增加(p<0.05),Mps1、Bub1和Mad-1的表达上调(p<0.05),CENP-E、BubR1和Mad-2的表达下调(p<0.05);2)CMA、CL和CB的频率增加(p<0.01);3)MN和NB的发生率增加(p<0.01)。
本研究首次揭示川贝母可导致人结肠上皮细胞出现有丝分裂畸变和基因组不稳定性,这些影响可能是SAC功能障碍的结果。